Insider Shareholders with Direct Ownership of Glycomimetics Inc (GLYC)
This section provides a comprehensive overview of the insiders with direct ownership of Glycomimetics Inc (GLYC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GLYCOMIMETICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,026,717 | 2,271,499 | 6,317,565 $2.65 Million | 17 |
Aug 08, 2024
Reduced 3.97%
|
|
|
Edwin Rock
Chief Medical Officer |
680,403 | 0 | 680,403 $285,769 | 7 |
Jun 21, 2024
Added 14.46%
|
|
Bvf Partners L P
> 10% Shareholder |
3,868,095 | 0 | 630,453 $264,790 | 3 |
Nov 04, 2020
Added 12.01%
|
| 241,310 | 84,176 | 515,194 $216,381 | 6 |
Mar 29, 2024
Added 0.64%
|
|
|
John L. Magnani
SVP of Research, CSO |
79,545 | 3,227 | 366,078 $153,752 | 3 |
Nov 11, 2022
Added 10.96%
|
|
Helen M. Thackray
SVP Clinical Development, CMO |
34,500 | 0 | 183,115 $76,908 | 1 |
Jan 20, 2021
Added 15.85%
|
|
Bruce S Johnson
SVP & Chief Commercial Officer |
13,500 | 0 | 138,980 $58,371 | 1 |
May 08, 2023
Added 8.85%
|
| 60,459 | 0 | 98,459 $41,352 | 4 |
Mar 29, 2024
Added 5.02%
|
|
|
Brian M. Hahn
SVP Finance, CFO |
77,260 | 6,617 | 70,643 $29,670 | 6 |
Jun 18, 2024
Added 19.85%
|
| 58,608 | 0 | 58,608 $24,615 | 4 |
Dec 29, 2023
Added 8.14%
|
|
| 36,750 | 0 | 36,750 $15,435 | 3 |
Jun 01, 2023
Added 36.36%
|
|
|
Armand Girard
SVP, Chief Business Officer |
31,500 | 2,339 | 29,161 $12,247 | 3 |
Nov 11, 2022
Added 18.23%
|
|
Harout Semerjian
Chief Executive Officer |
25,000 | 0 | 25,000 $10,500 | 1 |
Nov 11, 2022
Added 50.0%
|
| 24,828 | 0 | 24,828 $10,427 | 4 |
Mar 29, 2024
Added 15.59%
|
|
| 24,650 | 0 | 24,650 $10,353 | 2 |
Nov 11, 2022
Added 44.04%
|
|
| 5,250 | 0 | 5,250 $2,205 | 1 |
May 18, 2021
Added 50.0%
|